Morten Agertoug Nielsen

Morten Agertoug Nielsen

Professor

Member of:

  • VAR2CSA team


  1. 2021
  2. Published

    Development of a bispecific immune engager using a recombinant malaria protein

    Nordmaj, Mie Anemone, Roberts, M. E., Sachse, E. S., Dagil, Robert, Andersen, Anne Poder, Skeltved, Nanna, Grunddal, Kaare Villum, Erdogan, Sayit Mahmut, Choudhary, Swati, Gustavsson, Tobias, Ørum-madsen, M. S., Moskalev, I., Tian, W., Yang, Zhang, Clausen, Thomas Mandel, Theander, Thor Grundtvig, Daugaard, M., Nielsen, Morten Agertoug & Salanti, Ali, 2021, In: Cell Death & Disease. 12, 4, 11 p., 353.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Progress and insights toward an effective placental malaria vaccine

    Gamain, B., Chêne, A., Viebig, N. K., Tuikue Ndam, N. & Nielsen, Morten Agertoug, 2021, In: Frontiers in Immunology. 12, 634508.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    The immunogenicity of capsid-like particle vaccines in combination with different adjuvants using different routes of administration

    Janitzek, C. M., Carlsen, P. H. R., Thrane, Susan, Khanna, V. M., Jakob, V., Barnier-Quer, C., Collin, N., Theander, Thor Grundtvig, Salanti, Ali, Nielsen, Morten Agertoug & Sander, Adam F. , 2021, In: Vaccines. 9, 2, 131.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Two-component nanoparticle vaccine displaying glycosylated spike S1 domain induces neutralizing antibody response against SARS-CoV-2 variants

    van Oosten, L., Altenburg, J. J., Fougeroux, C., Geertsema, C., van den End, F., Evers, W. A. C., Westphal, A. H., Lindhoud, S., van den Berg, W., Swarts, D. C., Deurhof, L., Suhrbier, A., Le, T. T., Torres Morales, S., Myeni, S. K., Kikkert, M., Sander, A. F., de Jongh, W. A., Dagil, R., Nielsen, M. A. & 9 others, Salanti, Ali, Søgaard, M., Keijzer, T. M. P., Weijers, D., Eppink, M. H. M., Wijffels, R. H., van Oers, M. M., Martens, D. E. & Pijlman, G. P., 26 Oct 2021, In: mBio. 12, 5, e0181321.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. 2022
  7. Published

    A capsid virus-like particle-based SARS-CoV-2 vaccine induces high levels of antibodies and protects Rhesus macaques

    Volkmann, A., Koopman, G., Mooij, P., Verschoor, E. J., Verstrepen, B. E., Bogers, W. M. J. M., Idorn, M., Paludan, S. R., Vang, S., Nielsen, Morten Agertoug, Sander, Adam F. , Schmittwolf, C., Hochrein, H. & Chaplin, P., 2022, In: Frontiers in Immunology. 13, p. 857440

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice

    van Oosten, L., Yan, K., Rawle, D. J., Le, T. T., Altenburg, J. J., Fougeroux, Cyrielle Elyette, Goksøyr, L., de Jongh, W. A., Nielsen, Morten Agertoug, Sander, Adam F. , Pijlman, G. P. & Suhrbier, A., 2022, In: Journal of Virology. 96, 14, 00844-22.

    Research output: Contribution to journalLetterResearchpeer-review

  9. Published
  10. Published

    The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization

    Farzadfard, A., Pedersen, J. N., Meisl, G., Somavarapu, A. K., Alam, P., Goksøyr, L., Nielsen, Morten Agertoug, Sander, Adam F. , Knowles, T. P. J., Pedersen, J. S. & Otzen, D. E., 2022, In: Communications Biology . 5, 1, 123.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers

    Prentø, Jannick, Janitzek, C. M., Velázquez-Moctezuma, R., Sørensen, Andreas Holst Holmegaard, Jørgensen, T., Clemmensen, S., Soroka, V., Thrane, Susan, Theander, Thor Grundtvig, Nielsen, Morten Agertoug, Salanti, Ali, Bukh, Jens & Sander, Adam F. , 2022, In: npj Vaccines. 7, 148.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. 2023
  13. Published

    Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

    Doritchamou, J., Nielsen, M. A., Chêne, A., Viebig, N. K., Lambert, L. E., Sander, A. F., Semblat, J. P., Hundt, S., Orr-Gonzalez, S., Janitzek, C. M., Spiegel, A. J., Clemmensen, S. B., Thomas, M. L., Nason, M. C., Snow-Smith, M., Barnafo, E. K., Shiloach, J., Chen, B. B., Nadakal, S., Highsmith, K. & 15 others, Ouahes, T., Conteh, S., Sharma, A., Torano, H., Butler, B., Reiter, K., Rausch, K. M., Scaria, P. V., Anderson, C., Narum, D. L., Salanti, Ali, Fried, M., Theander, Thor Grundtvig, Gamain, B. & Duffy, P. E., 2023, In: Lab Animal. 52, 12, p. 315-323

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 3145601